Surgery for Gastroenteropancreatic Neuroendocrine Tumors (GEPNETS)

Endocrinology and Metabolism Clinics of North America

Volumn 40, Issue 1, 2011, Pages 163-171

  Boudreaux, J Philip ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Asymptomatic primary; Carcinoid; Cytoreduction; Gastric carcinoid; MEN; Mesenteric encasement; Midgut carcinoid

Indexed keywords

APPENDICEAL CARCINOID; CANCER GROWTH; CARCINOID; CLINICAL EFFECTIVENESS; COLONIC CARCINOID; CYTOREDUCTIVE SURGERY; ENDOCRINE TUMOR; GASTRINOMA; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; HUMAN; LAPAROSCOPIC SURGERY; LIVER METASTASIS; LIVER TRANSPLANTATION; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PREOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOID; TREATMENT RESPONSE; TUMOR VOLUME;

CARCINOID TUMOR; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENDOCRINE SURGICAL PROCEDURES; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS;

EID: 79951753576     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.12.004     Document Type: Review

References (30)

1. Plockinger U., Rindi G., Arnold R., et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumors. Neuroendocrinology 2005, 80(6):394-424.
2. Woltering E., Cundiff J., Lyons J. Neuroendocrine tumors of the gastroenteropancreatic axis. Principles and practice of surgical oncology 2010, 769-800. Lippincott Williams & Wilkins, Philadelphia (PA). H. Silberman, A. Silberman (Eds.).
3. Gibril F., Schumann M., Pace A., et al. Multiple endocrine neoplasia type I and the Zollinger-Ellison syndrome. A prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine 2004, 83:43-83.
4. Norton J.A., Melcher M.L., Gibril F., et al. Gastric carcinoid tumors in multiple endocrine neoplasia type I patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth and require surgical treatment. Surgery 2004, 136:1267-1274.
5. Rusznewski P., Fave G.D., Cadiot G., et al. European Neuroendocrine Society Guidelines (ENETS). Well differentiated gastric tumors/carcinomas. Neuroendocrinology 2006, 84:158-164.
6. Modlin L.M., Lye K.D., Kidd A. A five decade analysis of 13,715 carcinoid tumors. Cancer 2003, 97:934-959.
7. Tucker O.N., Crotty P.L., Conlon K.C. The management of insulinoma. Br J Surg 2006, 93:264-275.
8. Geoghegan J.G., Jackson J.E., Leno MP., et al. Localization and surgical management of insulinoma. Br J Surg 1994, 81:1025-1028.
9. Ramage J.K., Davies A.H., Ardill J., et al. Guidelines for the management of gastroenteropancreatic (including carcinoid) neuroendocrine tumors. Gut 2005, 54:1-16.
10. Kasono K., Hyodo T., Suminaga Y., et al. Contrast-enhanced endoscopic ultrasonography improves the preoperative localization of insulinomas. Endocr J 2002, 49:517-522.
11. Gress F.G., Barawi M., Kim D., et al. Preoperative localization of neuroendocrine tumor of the pancreas with endoscopic ultrasound-guided fine needle tattooing. Gastrointest Endosc 2002, 55:594-597.
12. Gouya H., Vignaux O., Augie J., et al. CT endoscopic sonography and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 2003, 181:987-992.
13. Gorma B., Charboneau J.W., James E.M., et al. Benign pancreatic insulinoma, preoperative and intraoperative sonographic localization. AJR Am J Roentgenol 1986, 147:929-934.
14. Hirimoto J., Feldstein V.A., LaBerge J.M., et al. Intraoperative ultrasound and preoperative localization detects all occult insulinomas. Arch Surg 2001, 136:1020-1026.
15. National Comprehensive Cancer Network, (NCCN): Practice guidelines in oncology. Web 2010. Available at: , V.1.2010. Accessed December 17, 2010. http://www.NCCN.org.
16. Falconi M., Plockinger U., Kwekkeboom D.J., et al. ENETS Guidelines. Well differentiated nonfunctioning pancreatic tumor/carcinoma. Neuroendocrinology 2006, 84:196-211.
17. Sarmiento J.M., Heywood G., Rubin J., et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003, 197(1):29-37.
18. Nilsson O., Cutsem E.V., Fave G.D., et al. Poorly differentiated tumors of the foregut (gastric, duodenal, pancreatic). ENETS Guidelines. Neuroendocrinology 2006, 84:212-215.
19. Makridis C., Oberg K., Juhlin C., et al. Surgical treatment of midgut carcinoid tumors. World J Surg 1990, 14:377-382.
20. Wang Y.Z., Boudreaux J.P., Joseph S., et al. Lymphatic mapping helps to define resection margins for midgut carcinoids. Surgery 2009, 146:993-997.
21. Guo Z., Li Q., Wilander E., et al. Clonality analysis of multifocal carcinoid tumors of the small intestine by X chromosome inactivation analysis. J Pathol 2000, 190:76-79.
22. Kobayashi K., Katsuma T., Yoshizawa S., et al. Indications for endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasound. Dis Colon Rectum 2005, 48(2):285-291.
23. Marouin J., Cocha H., Kvols L., et al. Guidelines for the diagnosis and management of carcinoid tumors from the Canadian National Carcinoid Expert Group. Acta Oncol 2004, 43:626-636.
24. Boudreaux J.P., Putty B., Frey DJ., et al. Surgical treatment of advanced stage carcinoid tumors, lessons learned. Ann Surg 2005, 241:839-846.
25. 123I-MIBG for detection and resection of lymph node metastases of a carcinoid not visualized by CT, MRI, or FDG-PET. Ann Nucl Med 2005, 19:611-615.
26. Benevento A., Dominioni L., Carcano G., et al. Intraoperative localization of gut endocrine tumors with radiolabeled somatostatin analogues and a gamma-detecting probe. Semin Surg Oncol 1998, 15(4):239-244.
27. Fahy B.N., Tang L.H., Klimstra D., et al. Carcinoid of the rectum and risk stratification (CaRRS): a strategy for preoperative outcome assessment. Ann Surg Oncol 2007, 14(2):396-404.
28. Mazzaferro V., Pulvirenti A., Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplant. J Hepatol 2007, 47:454-475.
29. Makidis C., Rostad J., Oberg K., et al. Progression of metastasis and symptom improvement from laparotomy in midgut carcinoid tumors. World J Surg 1996, 20:900-990.
30. Que F.G., Sarmiento J.M., Nagorney D. Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. Cancer Control 2002, 9(1):67-79.